Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed the rationale behind paclitaxel with bevacizumab and pembrolizumab in ovarian cancer.
Nicoletta Colombo, MD, PhD
Advertisement
Nicoletta Colombo, MD, PhD, is associate professor of obstetrics and gynecology at the University of Milan-Bicocca, director of the Ovarian Cancer Centre, and chair of the Program of Gynecology at the European Institute of Oncology.
Articles by Nicoletta Colombo, MD, PhD
New KEYNOTE-B96 data add to previous results showing progression-free survival (PFS) and overall survival (OS) improvements vs placebo.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Oral PCSK9 Inhibitor Enlicitide Matches Injectables in Lowering LDL Cholesterol
2
Improving Patient-Centered Cardiovascular Care for Older Adults
3
Introduction of Work Requirements to Medicaid Enrollment Could Destabilize Health: William Schpero, PhD, MPhil, MPH
4
Gefurulimab for MG Exhibits Lasting Efficacy, Safety in Topline PREVAIL Trial Data
5
